Table 2 Relationships between TIN density and clinical characteristics in TGCT patients (N = 102)
From: Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor
TIN density | ||||
|---|---|---|---|---|
Low (N = 81) | High (N = 21) | P value | ||
Age (years ± SD)a | 34.7 ± 11.2 | 31.7 ± 12.3 | 0.1438 | |
Tumor marker | ||||
LDH (N = 99) | Normal | 41 (42%) | 7 (7%) | 0.1768 |
High | 38 (38%) | 13 (13%) | ||
AFP (N = 99) | Normal | 55 (56%) | 12 (12%) | 0.2449 |
High | 23 (23%) | 9 (9%) | ||
βhCG (N = 101) | Normal | 31 (31%) | 7 (7%) | 0.6484 |
High | 49 (48%) | 14 (14%) | ||
T stage | T1 | 50 (49%) | 8 (8%) | 0.0513 |
T2-T4 | 31 (30%) | 13 (13%) | ||
S stage (N = 97) | S0-1 | 58 (60%) | 10 (10%) | 0.0275 |
S2-3 | 19 (20%) | 10 (10%) | ||
Stage | Stage I | 65 (64%) | 7 (7%) | <0.0001 |
Stage II-III | 16 (15%) | 14 (14%) | ||
IGCCC riskb | Good | 10 (33%) | 8 (27%) | 0.8051 |
Intermediate | 4 (13%) | 3 (10%) | ||
Poor | 2 (7%) | 3 (10%) | ||